Prescription-Drug-Spending_Regence

Why we're addressing the growth in medication spending

By Regence | June 16, 2015

Prescription drug costs are making headlines nationwide, from the Wall Street Journal to your local business journal. Historically, we have guided our members to generic versions for cost relief. But relief is getting hard to find.

A snapshot of specialty drug costs shows why. Drawing on data from affiliated plans across the country, the Blue Cross and Blue Shield Association’s “The Health of America” report shows specialty drugs are driving the growth in medication spending. For these drugs, there are no low-cost options.

Specialty drugs for conditions like multiple sclerosis, rheumatoid arthritis, psoriasis and hepatitis C now comprise 23% of all prescription spending – and that segment rose 20% last year.

When there’s only one of a drug, we have limited bargaining power on price. But as Blue plans, together we can use our influence to shift the places they are administered to lower-cost venues.

That’s just one way we advocate for our members to make health costs more affordable and sustainable.

Learn more about The Health of America.

Share:

Recent posts

FoF Social Media_FB_1

Share Your Fearless Moment

By Regence
March 21, 2017
Regence invites you to share your story of how you Live Fearless.
Regence_WA_CMYK_JPG

Leadership Changes at Regence

By Regence
March 15, 2017
This week, Don Antonucci has made the decision to resign from his role as President of Regence BlueShield to pursue an opportunity outside the company.
Medford2

Angela Dowling discusses the future of health care with Southern Oregon business leaders

By Regence
March 02, 2017
Regence BlueCross BlueShield of Oregon President Angela Dowling recently participated in a Medford/Jackson County Chamber of Commerce panel on the future of health care.